According to Benzinga Pro, Vertex Pharmaceuticals's peer group average for short interest as a percentage of float is 6.62%, ...

In a series of recent legal challenges initiated by the pharmaceutical industry against the US Department of Health and Human Services Office of ...

Vertex Pharmaceuticals (VRTX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...

Though things might not go that far, it's still worth planning ahead. Vertex Pharmaceuticals is best known for developing cystic fibrosis (CF) drugs. In patients with this condition, the normally ...

He praised the cooperation and joint coordination between the Egyptian Drug Authority and the World Health Organization to elevate the pharmaceutical ... challenge was to reach the same level in ...

U.S. pharma imports hit $200 billion in 2024, a 10% tariff could cost the sector $20 billion. Vertex and Alnylam are seen as most resilient to tariff, tax and Medicaid risks. Markets are messy ...

The Dividend chart for Vertex Pharmaceuticals (VRTX) shows us the per share payout over time. Dividends are a distribution to shareholders, and they define how much money a company is roviding to its ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Vertex Pharmaceuticals (VRTX – Research Report) and Apellis Pharmaceuticals (APLS – Research Report).

Boasberg of the US District Court for the District of Columbia upheld a US Department of Health and Human Services advisory opinion that found that Vertex Pharmaceuticals could not offer remuneration ...

We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against other best ...

We recently published a list of Jim Cramer Looked At These 23 Stocks Recently. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against ...